Fungi Bioactive Metabolites Integration of Pharmaceutical Applications /
This book presents the exploration and exploitation of various bioactive metabolites obtained from fungi isolated from diverse habitats for pharmaceutical applications. Various fungal sources have been brought under one umbrella ranging from endophytes, marine fungi, endolichenic fungi to fungi exis...
Saved in:
| Corporate Author: | |
|---|---|
| Other Authors: | , , |
| Format: | Electronic eBook |
| Language: | English |
| Published: |
Singapore :
Springer Nature Singapore : Imprint: Springer,
2024.
|
| Edition: | 1st ed. 2024. |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/978-981-99-5696-8 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000nam a22000005i 4500 | ||
|---|---|---|---|
| 001 | 978-981-99-5696-8 | ||
| 003 | DE-He213 | ||
| 005 | 20251113175255.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 240228s2024 si | s |||| 0|eng d | ||
| 020 | |a 9789819956968 |9 978-981-99-5696-8 | ||
| 024 | 7 | |a 10.1007/978-981-99-5696-8 |2 doi | |
| 050 | 4 | |a R850.A1-854 | |
| 050 | 4 | |a QH315-320 | |
| 072 | 7 | |a MBGR |2 bicssc | |
| 072 | 7 | |a MED106000 |2 bisacsh | |
| 072 | 7 | |a MBGR |2 thema | |
| 082 | 0 | 4 | |a 610.72 |2 23 |
| 245 | 1 | 0 | |a Fungi Bioactive Metabolites |h [electronic resource] : |b Integration of Pharmaceutical Applications / |c edited by Sunil Kumar Deshmukh, Jacqueline Aparecida Takahashi, Sanjai Saxena. |
| 250 | |a 1st ed. 2024. | ||
| 264 | 1 | |a Singapore : |b Springer Nature Singapore : |b Imprint: Springer, |c 2024. | |
| 300 | |a XVII, 762 p. 1 illus. |b online resource. | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 341 | 0 | |b Table of contents navigation |2 onix | |
| 341 | 0 | |b Single logical reading order |2 onix | |
| 341 | 0 | |b Short alternative textual descriptions |2 onix | |
| 341 | 0 | |b Use of color is not sole means of conveying information |2 onix | |
| 341 | 0 | |b Use of high contrast between text and background color |2 onix | |
| 341 | 0 | |b Next / Previous structural navigation |2 onix | |
| 341 | 0 | |b All non-decorative content supports reading without sight |2 onix | |
| 347 | |a text file |b PDF |2 rda | ||
| 505 | 0 | |a Part I: Bioactive Compounds from Endophytic Fungi -- Chapter 1. Recent Advances in Pharmaceutically Important Compounds from Endophytic Fungi -- Chapter 2. Pharmaceutically Important Compound Produced by Endophytic Fungi Having Anti-Infective Activity -- Chapter 3. Fungal Endophytes: An Accessible Natural Repository for Discovery of Bioactive Compounds -- Part II: Endolichenic Fungi: A Source of New Chemical Entities -- Chapter 4. Endolichenic Fungi as a Source of Pharmaceutically Active Compounds -- Chapter 5. Endolichenic Fungi, an Emerging Source of Bioactive Compounds: A Pharmaceutical Perspective -- Part III: Marine Fungi as a Source of Medicinal Compounds -- Chapter 6. Antibiofilm Metabolites from Sponge-derived Aspergillus, Penicillium, and Fusarium for the Antibiotic Pipeline -- Chapter 7. Marine Fungi as a Bioresource of Medicinal Entities -- Chapter 8. Natural Bioactive Products from Marine Fungi against Bacterial Infection. Part IV: Fungi as a Bioresource of Pharmacologically Active Agents -- Chapter 9. Penicillium: A Treasure-Trove for Antimycobacterial and Antioxidant Metabolites -- Chapter 10. Metabolites from Fungi: a Promising Source of Lead Compounds against Cancer -- Chapter 11. Edible Mushrooms Substances as Natural Prevention in Autoimmunological Diseases -- Chapter 12. New Antifungal Drugs: Discovery and Therapeutic Potential -- Chapter 13. Fungal Enzyme Inhibitors: Potent Repository of Lead Compounds to Curb Cancer -- Chapter 14. Bioactive Metabolites from Fungi with Anti-Inflammatory and Anti-Thrombotic Properties; Current Status and Future Perspectives for Drug Development -- Chapter 15. Progress in the Development of Fungal Metabolites as New Drugs for Human Mycoses -- Part V: Fungi from Extremophilic Environment/Unique Ecosystems -- Chapter 16. Uncovering the Desert Fungal Enigma: An Attractive Resource for Biopharmaceuticals -- Chapter 17. Bioactive Metabolites Produced by Fungi Present inAntarctic, Arctic and Alpine Ecosystems -- Part VI: Novel Strategies to Screen or Enhance Secondary Metabolite Production -- Chapter 18. Enhancing Chemical Diversity of Fungal Secondary Metabolite by OSMAC Strategy -- Chapter 19. Epigenetic Regulation of Fungal Secondary Metabolites for the Enhancement of Therapeutically Active Compounds -- Chapter 20. Strategies for Enhancing the Production of Echinocandin -- Part VII: Other by Products of Fungal Metabolism with Medicinal Applications -- Chapter 21. Fungal Pigments: Applications and Their Medicinal Potential -- Chapter 22. A Brief Insight into Peptide and Non-Peptide Drugs of Fungal Origin -- Chapter 23. Kojic Acid from Aspergillus wentii: A Journey from Isolation to Application -- Part VIII: Bioinformatics and Fungal Biotransformations in Pharmaceutical Drug Development -- Chapter 24. How Does Bioinformatics Play a Role in Fungal Drug Discovery? -- Chapter 25. Fungal Biotransformation of Steroids: History, Current Status, and Future Prospects. . | |
| 520 | |a This book presents the exploration and exploitation of various bioactive metabolites obtained from fungi isolated from diverse habitats for pharmaceutical applications. Various fungal sources have been brought under one umbrella ranging from endophytes, marine fungi, endolichenic fungi to fungi existing in the extremophilic conditions like desert and Antarctica and Artic environment. The book tries to cover maximally the range of the pharmaceutical applications wherein these bioactive agents from fungi have been exploited or are in the clinical pipelines and primarily include antibacterial, antifungal, antibiofilm, anticancer, antioxidant, autoimmunological, anti-inflammatory, and anti-thrombotic diseases. The book further emphasizes on the novel strategies to screen or enhance secondary metabolite production. Some other topics includes peptides, nonpeptides drugs, pigments, and enhancement of production of Echinocandin and Kojic acid. The role of bioinformatics in drug discovery and biotransformations have also been discussed. This book is going to be a comprehensive treatise and a valuable source for mycologists, biotechnologists, microbiologists, biotechnologists, and undertaking research in pharmaceutical sector as well as academia in setting up their research aspirations for using fungi in the process of drug discovery and development. . | ||
| 532 | 8 | |a Accessibility summary: This PDF does not fully comply with PDF/UA standards, but does feature limited screen reader support, described non-text content (images, graphs), bookmarks for easy navigation and searchable, selectable text. Users of assistive technologies may experience difficulty navigating or interpreting content in this document. We recognize the importance of accessibility, and we welcome queries about accessibility for any of our products. If you have a question or an access need, please get in touch with us at accessibilitysupport@springernature.com. | |
| 532 | 8 | |a No reading system accessibility options actively disabled | |
| 532 | 8 | |a Publisher contact for further accessibility information: accessibilitysupport@springernature.com | |
| 650 | 0 | |a Medicine |x Research. | |
| 650 | 0 | |a Biology |x Research. | |
| 650 | 0 | |a Drug delivery systems. | |
| 650 | 0 | |a Molecular biology. | |
| 650 | 0 | |a Molecular ecology. | |
| 650 | 0 | |a Cytology. | |
| 650 | 1 | 4 | |a Biomedical Research. |
| 650 | 2 | 4 | |a Drug Delivery. |
| 650 | 2 | 4 | |a Molecular Biology. |
| 650 | 2 | 4 | |a Molecular Ecology. |
| 650 | 2 | 4 | |a Cell Biology. |
| 700 | 1 | |a Deshmukh, Sunil Kumar. |e editor. |0 (orcid)0000-0001-5395-9512 |1 https://orcid.org/0000-0001-5395-9512 |4 edt |4 http://id.loc.gov/vocabulary/relators/edt | |
| 700 | 1 | |a Takahashi, Jacqueline Aparecida. |e editor. |4 edt |4 http://id.loc.gov/vocabulary/relators/edt | |
| 700 | 1 | |a Saxena, Sanjai. |e editor. |0 (orcid)0000-0003-0025-8362 |1 https://orcid.org/0000-0003-0025-8362 |4 edt |4 http://id.loc.gov/vocabulary/relators/edt | |
| 710 | 2 | |a SpringerLink (Online service) | |
| 773 | 0 | |t Springer Nature eBook | |
| 776 | 0 | 8 | |i Printed edition: |z 9789819956951 |
| 776 | 0 | 8 | |i Printed edition: |z 9789819956975 |
| 776 | 0 | 8 | |i Printed edition: |z 9789819956982 |
| 856 | 4 | 0 | |u https://doi.org/10.1007/978-981-99-5696-8 |
| 912 | |a ZDB-2-SBL | ||
| 912 | |a ZDB-2-SXB | ||
| 950 | |a Biomedical and Life Sciences (SpringerNature-11642) | ||
| 950 | |a Biomedical and Life Sciences (R0) (SpringerNature-43708) | ||